Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Alopecia areata totalis and universalis: a multicenter review of 132 patients in Spain

Artikel i vetenskaplig tidskrift
Författare S. Vano-Galvan
P. Fernandez-Crehuet
R. Grimalt
M. J. Garcia-Hernandez
R. Rodrigues-Barata
S. Arias-Santiago
A. Molina-Ruiz
E. Garcia-Lora
J. Dominguez-Cruz
A. Brugues
J. Ferrando
C. Serrano-Falcon
S. Serrano
John Paoli
F. Camacho
Publicerad i Journal of the European Academy of Dermatology and Venereology
Volym 31
Nummer/häfte 3
Sidor 550-556
ISSN 0926-9959
Publiceringsår 2017
Publicerad vid Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi, Avdelningen för dermatologi och venereologi
Sidor 550-556
Språk en
Länkar doi.org/10.1111/jdv.13959
Ämnesord pulse methylprednisolone therapy, term-follow-up, corticosteroid-therapy, systemic corticosteroids, oral corticosteroids, efficacy, update, combination, experience, methotrexate, Dermatology
Ämneskategorier Dermatologi och venereologi

Sammanfattning

BackgroundAlopecia areata totalis (AAT) and universalis (AAU) pose a therapeutic challenge. ObjectiveTo describe the clinical and epidemiological features, therapeutic response and prognostic factors in a large series of patients diagnosed with AAT and AAU. MethodsThis retrospective multicenter study included patients diagnosed with AAT/AAU with a minimum follow-up of 12 months. Response was assessed based on the regrowth of scalp hair. ResultsIn all, 132 patients (92 women and 40 men) - 80 (61%) diagnosed with AAU and 52 (39%) diagnosed with AAT - were included. The median time between the presentation of alopecia areata (AA) and the development of extensive AA was 1 year and it was less than 4 years in 121 patients (91%). There was an initial response to treatment in 64% of patients, although only 14% presented a persistent response. Adverse side effects from the medications used were detected in 33% of patients. The prognostic factors associated with poor response were the presence of AAU and a positive family history of AA. ConclusionsTreatment of AAT and AAU is challenging. Although an initial regrowth may be achieved, the duration of response is usually short. There were no significant differences on the effectiveness or duration of response between the various systemic therapies.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?